Abridge, founded in 2018 by cardiologist Shiv Rao alongside Sandeep Konam and Florian Metze out of the Pittsburgh Health Data Alliance, a collaboration between UPMC, Carnegie Mellon, and the University of Pittsburgh, listens to patient-clinician conversations and turns them into structured clinical documentation, aiming to hand doctors back the time spent typing notes after every visit.
That documentation focus has expanded into a broader platform: Abridge is deployed at Mayo Clinic, Duke Health, Johns Hopkins, Kaiser Permanente, and more than 300 other health systems, and KLAS named it #1 Best in KLAS for Ambient AI in Revenue Cycle Management for two consecutive years through February 2026. The company has raised roughly $830 million total, including a $300 million Series E and a follow-on extension at a $5.3 billion valuation, with a strategic investment from Eli Lilly backing expansion into billing, clinical decision support, and pharmaceutical trial screening.
Enterprise pricing is negotiated per health system and requires a sales conversation. For a hospital or health system that wants ambient clinical documentation proven at large-scale deployments like Mayo Clinic and Johns Hopkins, rather than a newer platform without that scale of validation, Abridge's enterprise track record addresses that directly.
